Interleukin-8/CXCR1 Signaling Contributes to the Progression of Pulmonary Adenocarcinoma Resulting in Malignant Pleural Effusion

Cells. 2024 Jun 3;13(11):968. doi: 10.3390/cells13110968.

Abstract

Pulmonary adenocarcinoma (PADC) treatment limited efficacy in preventing tumor progression, often resulting in malignant pleural effusion (MPE). MPE is filled with various mediators, especially interleukin-8 (IL-8). However, the role of IL-8 and its signaling mechanism within the fluid microenvironment (FME) implicated in tumor progression warrants further investigation. Primary cultured cells from samples of patients with MPE from PADC, along with a commonly utilized lung cancer cell line, were employed to examine the role of IL-8 and its receptor, CXCR1, through comparative analysis. Our study primarily assessed migration and invasion capabilities, epithelial-mesenchymal transition (EMT), and cancer stem cell (CSC) properties. Additionally, IL-8 levels in MPE fluid versus serum, along with immunohistochemical expression of IL-8/CXCR1 signaling in tumor tissue and cell blocks were analyzed. IL-8/CXCR1 overexpression enhanced EMT and CSC properties. Furthermore, the immunocytochemical examination of 17 cell blocks from patients with PADC and MPE corroborated the significant correlation between upregulated IL-8 and CXCR1 expression and the co-expression of IL-8 and CXCR1 in MPE with distant metastasis. In summary, the IL-8/ CXCR1 axis in FME is pivotal to tumor promotion via paracrine and autocrine signaling. Our study provides a therapeutic avenue for improving the prognosis of PADC patients with MPE.

Keywords: CXCR1; cancer stem cell; epithelial-mesenchymal transition; fluid microenvironment; interleukin-8; interleukin-8/CXCR1 signaling.

MeSH terms

  • Adenocarcinoma of Lung* / complications
  • Adenocarcinoma of Lung* / genetics
  • Adenocarcinoma of Lung* / metabolism
  • Adenocarcinoma of Lung* / pathology
  • Aged
  • Cell Line, Tumor
  • Cell Movement
  • Disease Progression
  • Epithelial-Mesenchymal Transition*
  • Female
  • Humans
  • Interleukin-8* / metabolism
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / metabolism
  • Lung Neoplasms* / pathology
  • Male
  • Middle Aged
  • Neoplastic Stem Cells / metabolism
  • Neoplastic Stem Cells / pathology
  • Pleural Effusion, Malignant* / metabolism
  • Pleural Effusion, Malignant* / pathology
  • Receptors, Interleukin-8A* / genetics
  • Receptors, Interleukin-8A* / metabolism
  • Signal Transduction*
  • Tumor Microenvironment

Substances

  • CXCL8 protein, human
  • Interleukin-8
  • Receptors, Interleukin-8A

Grants and funding

This study was partly supported by the Tri-Service General Hospital (Grant Nos TSGH-E-113245, TSGH-E-111222, TSGH-E-113299, TSGH-PH-E110017, 801GB112132) and the Kaohsiung Veterans General Hospital (KSVGH111-204).